SPOTLIGHT -
2017 PharmD Candidate at University of Connecticut School of Pharmacy, Storrs, Conn.
Atezolizumab for Urothelial Carcinoma and Non-Small Cell Lung Cancer
Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.
